These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 6602587)
21. Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristics. Jones RN; Barry AL Rev Infect Dis; 1983; 5 Suppl 1():S108-26. PubMed ID: 6221381 [TBL] [Abstract][Full Text] [Related]
22. Comparative affinities for penicillin-binding proteins of multipolar ionic amphoteric cephalosporins in gram-negative bacteria. Fontana R; Valisena S; Cornaglia G J Chemother; 1996 Feb; 8 Suppl 2():23-30. PubMed ID: 8738843 [TBL] [Abstract][Full Text] [Related]
23. Mechanism of action of cephalosporins and resistance caused by decreased affinity for penicillin-binding proteins in Bacteroides fragilis. Yotsuji A; Mitsuyama J; Hori R; Yasuda T; Saikawa I; Inoue M; Mitsuhashi S Antimicrob Agents Chemother; 1988 Dec; 32(12):1848-53. PubMed ID: 3266730 [TBL] [Abstract][Full Text] [Related]
24. The final goal: penicillin-binding proteins and the target of cephalosporins. Fontana R; Cornaglia G; Ligozzi M; Mazzariol A Clin Microbiol Infect; 2000; 6 Suppl 3():34-40. PubMed ID: 11449647 [No Abstract] [Full Text] [Related]
25. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem. Fukuoka T; Ohya S; Utsui Y; Domon H; Takenouchi T; Koga T; Masuda N; Kawada H; Kakuta M; Kubota M; Ishii C; Ishii C; Sakagawa E; Harasaki T; Hirasawa A; Abe T; Yasuda H; Iwata M; Kuwahara S Antimicrob Agents Chemother; 1997 Dec; 41(12):2652-63. PubMed ID: 9420035 [TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamases. Stone GW; Zhang Q; Castillo R; Doppalapudi VR; Bueno AR; Lee JY; Li Q; Sergeeva M; Khambatta G; Georgopapadakou NH Antimicrob Agents Chemother; 2004 Feb; 48(2):477-83. PubMed ID: 14742198 [TBL] [Abstract][Full Text] [Related]
27. Interaction of the novel penem CGP 31 608 and its enantiomer with type Id beta-lactamase and penicillin-binding proteins. Mett H; Schacher B; Schneider P; Zak O Eur J Clin Microbiol; 1987 Dec; 6(6):674-8. PubMed ID: 3126060 [TBL] [Abstract][Full Text] [Related]
28. Mechanisms of resistance of enterococci to beta-lactam antibiotics. Fontana R; Canepari P; Lleò MM; Satta G Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):103-5. PubMed ID: 2180705 [TBL] [Abstract][Full Text] [Related]
29. Differences between ceftizoxime and its stereoisomer in antibacterial activity and affinity for penicillin-binding proteins. Shigi Y; Kojo H; Wakasugi M; Nishida M Antimicrob Agents Chemother; 1981 Mar; 19(3):393-6. PubMed ID: 7018389 [TBL] [Abstract][Full Text] [Related]
30. Cephabacin M1-6, new 7-methoxycephem antibiotics of bacterial origin. I. A producing organism, fermentation, biological activities, and mode of action. Nozaki Y; Katayama N; Tsubotani S; Ono H; Okazaki H J Antibiot (Tokyo); 1985 Sep; 38(9):1141-51. PubMed ID: 3905734 [TBL] [Abstract][Full Text] [Related]
31. [Grouping of the genes of biosynthesis and resistance to beta-lactam antibiotics in cephamycin-C producing actinomycetes]. Liras P; Coque JJ; García-Calzada J; Pérez Llarena FJ; Cardoza RE Microbiologia; 1994; 10(1-2):49-56. PubMed ID: 7946127 [TBL] [Abstract][Full Text] [Related]
32. The interactions of [14C]cefotetan with penicillin binding proteins of a wide variety of Gram-positive and gram-negative species. Nolan RD; Jude DA J Antimicrob Chemother; 1983 Jan; 11 Suppl():169-77. PubMed ID: 6573313 [TBL] [Abstract][Full Text] [Related]
33. In vitro antibacterial activity of KP-736, a new cephem antibiotic. Maejima T; Inoue M; Mitsuhashi S Antimicrob Agents Chemother; 1991 Jan; 35(1):104-10. PubMed ID: 2014964 [TBL] [Abstract][Full Text] [Related]
34. Mechanism of action of the new orally active cephalosporin FK027. Shigi Y; Matsumoto Y; Kaizu M; Fujishita Y; Kojo H J Antibiot (Tokyo); 1984 Jul; 37(7):790-6. PubMed ID: 6381449 [TBL] [Abstract][Full Text] [Related]
35. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties. Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880 [TBL] [Abstract][Full Text] [Related]
36. In vitro investigation of BK-218, a new oral and parenteral cephalosporin. Szabó I; Barabás J; Tar A; Kiss L; Filep M; Schmidt T; Marossy K; Tóth-Martinez B; Barabás G; Hernádi F Antimicrob Agents Chemother; 1990 Feb; 34(2):349-54. PubMed ID: 2109582 [TBL] [Abstract][Full Text] [Related]
37. Penicillin-binding proteins and induction of AmpC beta-lactamase. Sanders CC; Bradford PA; Ehrhardt AF; Bush K; Young KD; Henderson TA; Sanders WE Antimicrob Agents Chemother; 1997 Sep; 41(9):2013-5. PubMed ID: 9303404 [TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics. Okamoto S; Hamana Y; Inoue M; Mitsuhashi S Antimicrob Agents Chemother; 1987 Jul; 31(7):1111-6. PubMed ID: 3499115 [TBL] [Abstract][Full Text] [Related]
39. The role of penicillin-proteins in the action of cephalosporins against Escherichia coli and Salmonella typhimurium. Chase HA; Fuller C; Reynolds PE Eur J Biochem; 1981 Jul; 117(2):301-10. PubMed ID: 7023942 [No Abstract] [Full Text] [Related]